Recursion Pharmaceuticals (RXRX) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.45
-0.41
-0.37
-0.33

Details

Expected EPS
-0.332835
Actual EPS
-0.34
Surprise EPS
-0.01
Surprise Percent
-2.15%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.34⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts